Esterified Pectin TLR2 Binding for Inflammatory Disease Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing and treating inflammatory diseases, such as arthritis and gastrointestinal disturbances, often result in undesirable side effects and costly surgical procedures, and there is a need for alternative approaches that do not rely on invasive treatments or antibiotic use in animals.
Innovation Solution
The use of esterified pectins with a degree of esterification of less than 65% to prevent, reduce, or treat inflammatory disorders by binding Toll-like receptor 2 (TLR2), thereby regulating intestinal barrier function and immune responses, which can be incorporated into food or feed compositions for human and animal consumption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If steroidal cortisone derivatives and NSAIDs are used to treat inflammatory diseases, then anti-inflammatory effects are achieved, but undesirable side effects occur
Solution Approach 1:
The patent uses pectin as an intermediary substance that modulates the immune response by interacting with Toll-like receptors (TLR2, TLR4) and dendritic cells, thereby achieving anti-inflammatory effects without the direct toxic effects of conventional drugs. The pectin acts as a natural mediator that regulates immune system activity rather than suppressing it pharmacologically.
Solution Approach 2:
The patent specifies precise parameter ranges for pectin effectiveness: degree of esterification between 20-60% (preferably 30-50%), and concentration in food compositions of 0.1-10% (preferably 0.5-5%). These parameter optimizations ensure therapeutic efficacy while minimizing side effects compared to conventional drugs.
2Reliability
If joint implants are used to treat severe arthritis, then functional improvement is achieved, but invasive surgery and lengthy recovery are required
Solution Approach 1:
The patent applies pectin preventively through food compositions to maintain intestinal barrier function and regulate immune responses before inflammatory diseases progress to severe stages requiring surgery. This preliminary dietary intervention can prevent the need for invasive joint implants by managing inflammation early in the disease course.
Solution Approach 2:
The pectin-based food composition enables the body's own immune system to regulate inflammation through natural mechanisms rather than requiring external surgical intervention. The pectin stimulates the immune system's self-regulatory pathways via TLR modulation, allowing the body to heal itself without invasive procedures.
3Reliability
If antibiotics are used in animals to prevent gastrointestinal disturbances, then disease prevention is achieved, but antibiotic resistance and health concerns arise
Solution Approach 1:
The patent uses pectin as a natural intermediary that modulates gut immune responses and maintains intestinal barrier function without the antimicrobial effects of antibiotics. By interacting with Toll-like receptors and dendritic cells in the gut-associated lymphoid tissue, pectin prevents gastrointestinal disturbances through immune regulation rather than pathogen elimination, avoiding antibiotic resistance.
Solution Approach 2:
The patent specifies pectin concentration ranges of 0.1-10% in animal feed compositions, with degree of esterification of 20-60%, to achieve disease prevention efficacy equivalent to antibiotics without their harmful side effects. These optimized parameters ensure sufficient immune modulation while maintaining safety.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively minimizes the risk of contracting inflammatory diseases, alleviates symptoms, and improves overall health and welfare with lower pectin concentrations, reducing the need for invasive treatments and antibiotic use, while maintaining efficacy.
Implementation Method 1
The pectins bind to Toll-like receptor 2 (TLR2), thereby regulating intestinal barrier function and immune responses
Data Source
AI summary
This invention relates generally to compositions and methods for combating inflammatory disease and particularly to the use of feed or food compositions for preventing, reducing and/or treating inflammatory disorders, diseases, or discomforts, wherein the compositions comprising at least one specific pectin.